Publications

Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan.

Tarr, PE; Kuppens, L; Jones, TC; Ivanoff, B; Aparin, PG; HEYMANN, DL;

1999

The American journal of tropical medicine and hygiene, (1999).61 1 10.4269/ajtmh.1999.61.163.

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.

Momeni, AZ; Jalayer, T; Emamjomeh, M; Khamesipour, A; Zicker, F; Ghassemi, RL; Dowlati, Y; Sharifi, I; Aminjavaheri, M; Shafiei, A; Alimohammadian, MH; Hashemi-Fesharki, R; Nasseri, K; Godal, T; SMITH, PG; Modabber, F;

1999

Vaccine, (1999).17 5 10.1016/s0264-410x(98)00220-5.

Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.

Haywood, M; CONWAY, DJ; WEISS, H; Metzger, W; D'ALESSANDRO, U; Snounou, G; Targett, G; GREENWOOD, B;

1999

Transactions of the Royal Society of Tropical Medicine and Hygiene, (1999).93 Suppl 1, 10.1016/s0035-9203(99)90330-9.

Analysis of the original antigenic sin antibody response to the major outer membrane protein of Chlamydia trachomatis.

Berry, JD; PEELING, RW; Brunham, RC;

1999

The Journal of infectious diseases, (1999).179 1 10.1086/314538.

Evaluation of vaccines for the prevention of pneumonia in children in developing countries.

Mulholland, K; Levine, O; Nohynek, H; GREENWOOD, BM;

1999

Epidemiologic reviews, (1999).21 1 10.1093/oxfordjournals.epirev.a017987.

An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa.

Leach, A; Hilton, S; GREENWOOD, BM; Manneh, E; Dibba, B; Wilkins, A; MULHOLLAND, EK;

1999

Social science & medicine (1982), (1999).48 2 10.1016/s0277-9536(98)00317-7.

Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.

Ward, SJ; Douce, G; Dougan, G; WREN, BW;

1999

Infection and immunity, (1999).67 10 10.1128/iai.67.10.5124-5132.1999.

Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.

Ward, SJ; Douce, G; Figueiredo, D; Dougan, G; WREN, BW;

1999

Infection and immunity, (1999).67 5 10.1128/iai.67.5.2145-2152.1999.

Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania.

Obasi, A; Mosha, F; Quigley, M; Sekirassa, Z; Gibbs, T; Munguti, K; TODD, J; GROSSKURTH, H; MAYAUD, P; Changalucha, J; Brown, D; MABEY, D; HAYES, R;

1999

The Journal of infectious diseases, (1999).179 1 10.1086/314555.

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective.

EDMUNDS, WJ; MEDLEY, GF; Nokes, DJ;

1999

Statistics in medicine, (1999).18 233.0.co;2-3" target="_blank"> 10.1002/(sici)1097-0258(19991215)18:23<3263::aid-sim315>3.0.co;2-3 .